US Stock MarketDetailed Quotes

MRUS Merus

Watchlist
  • 42.940
  • -0.800-1.83%
Close Dec 10 16:00 ET
  • 42.750
  • -0.190-0.44%
Post 17:33 ET
2.94BMarket Cap-10655P/E (TTM)

About Merus Company

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Company Profile

SymbolMRUS
Company NameMerus
Listing DateMay 19, 2016
Issue Price10.00
Founded2003
CEODr. Sven Ante Lundberg, M.D.
MarketNASDAQ
Employees229
Fiscal Year Ends12-31
AddressUppsalalaan 17,3rd-4th Floor
CityUtrecht
ProvinceUtrecht
CountryNetherlands (the)
Zip Code3584 CM
Phone31-30-253-88-00
Websitehttp://www.merus.nl

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sven Ante Lundberg, M.D.
  • Director, President and Chief Executive Officer
  • 4.67M
  • Peter B. Silverman, J.D.
  • Chief Operating Officer and General Counsel
  • 1.95M
  • Gregory D. Perry
  • Chief Financial Officer
  • 6.21M
  • Harry Shuman
  • Chief Accounting Officer
  • --
  • Dr. Fabian Zohren, M.D.,PhD
  • Chief Medical Officer
  • --
  • Dr. Anand Mehra, M.D.
  • Chairman of the Board
  • 417.56K
  • Dr. Maxine Gowen,PhD
  • Independent Director
  • 305.06K
  • Paolo Pucci
  • Independent Director
  • 309.56K
  • Mark T. Iwicki
  • Independent Director
  • 311.06K
  • Jason Haddock
  • Independent Director
  • --
  • Dr. Victor Sandor, C.M.,M.D.
  • Independent Director
  • 303.56K
  • Len Kanavy
  • Independent Director
  • 303.56K
Heat List
US
Overall
Symbol
Price
% Chg

No Data